Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab Monotherapy”

Showing 11 of 0 results

Not applicableStudy completedNCT01474291
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 608
Post-approval studies (Phase 4)Study completedNCT01399697
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 261
Large-scale testing (Phase 3)Study completedNCT03155347
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 340
Large-scale testing (Phase 3)Study completedNCT01987479
What this trial is testing

A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 150
Not applicableStudy completedNCT05133895
What this trial is testing

Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis

Who this might be right for
Chronic PeriaortitisTocilizumab Monotherapy
Peking Union Medical College Hospital 12
Large-scale testing (Phase 3)Study completedNCT02011334
What this trial is testing

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 285
Not applicableEnded earlyNCT01643863
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1
Large-scale testing (Phase 3)Study completedNCT01254331
What this trial is testing

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 51
Large-scale testing (Phase 3)Study completedNCT01995201
What this trial is testing

Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 401
Large-scale testing (Phase 3)Study completedNCT01587989
What this trial is testing

RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 77
Large-scale testing (Phase 3)Study completedNCT01007435
What this trial is testing

Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,162

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation